Anthem Biosciences Ltd. (ANTHEM): Anthem Biosciences Share Price rises 2.18% to Rs 928.40
- September 17, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price is in focus today after the stock rose 2.18% to Rs 928.40, adding Rs 19.80 from the previous close of Rs 908.60. The company’s market capitalisation stands at Rs 53,106.88 crore, which places the move in a clear market-cap context for investors tracking Anthem Biosciences Share Price Today. The stock opened at Rs 914.00, touched an intraday high of Rs 932.05 and a low of Rs 905.00, while turnover stood at Rs 6.04 crore. The supplied data confirms the price event, but it does not establish a company-specific catalyst. For readers scanning Anthem Biosciences Stock News, this is a same-day share price rise that stands out because the valuation remains elevated and the sector comparison is detailed enough to frame the move without speculation. Univest tracks such market updates with a focus on verified numbers and clean context.
The movement matters because Anthem Biosciences Share Price Today is trading at Rs 928.40 against an already high P/E of 88.9 and P/B of 16.36. On the operating side, ROE is 21.98% and ROCE is 29.62%, while EPS is Rs 10.22 and book value is Rs 55.53. The dividend yield is 0.22%. That mix places Anthem Biosciences Stock News firmly in the category of a stock where price action, valuation and business quality need to be read together. Univest presents the event as a verified share price rise rather than a forecast or recommendation.
Anthem Biosciences Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 928.4 |
| Previous Close | Rs 908.6 |
| Today's Move | Rs 19.8 (+2.18%) |
| Open | Rs 914 |
| High | Rs 932.05 |
| Low | Rs 905 |
| Turnover | Rs 6.04 crore |
| Market Capitalisation | Rs 53,106.88 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Ltd. (ANTHEM) rose to Rs 928.4 from the previous close of Rs 908.6, a move of Rs 19.8 or 2.18%. The stock opened at Rs 914, reached a high of Rs 932.05, recorded a low of Rs 905.
Anthem Biosciences Share Price Today rose 2.18% as the stock moved from Rs 908.60 to Rs 928.40, with the day’s range stretching from Rs 905.00 to Rs 932.05. The opening price was Rs 914.00, so the session showed a steady advance during the day rather than a flat move. Turnover was Rs 6.04 crore. That is the full factual price picture available for today’s Anthem Biosciences Share Price rise.
For readers following Anthem Biosciences Share Price Live, the important point is that the move is a same-day gain and not a statement about a confirmed trigger. Univest is therefore treating the session as a price event first, with the rest of the article framing the financial, sector and peer context around it.
Anthem Biosciences Ltd. (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 53,106.88 crore |
| P/E Ratio | 88.9x |
| P/B Ratio | 16.36x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.22% |
Anthem Biosciences Ltd. (ANTHEM) fundamental metrics show P/E 88.9x, P/B 16.36x, ROE 21.98%, ROCE 29.62%. These figures provide context only and are not a buy or sell signal.
Anthem Biosciences Ltd. has a market capitalisation of Rs 53106.88 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 88.9x, P/B at 16.36x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 21.98% and ROCE of 29.62%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 10.22, book value per share of Rs 55.53, dividend yield of 0.22%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 31.35x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 88.9x |
| Benchmark Median P/E | 31.35x |
| Benchmark Average P/E | 47.81x |
| Benchmark P/E Range | 3.45x to 661.74x |
| Company P/B Ratio | 16.36x |
| Benchmark Median P/B | 2.98x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.78% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.65% |
| Company Market Capitalisation | Rs 53,106.88 crore |
| Benchmark Median Market Cap | Rs 735.67 crore |
Anthem Biosciences Ltd. (ANTHEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 88.9x, which is above the benchmark median of 31.35x, a difference of +183.57%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Anthem Biosciences Ltd. (ANTHEM) has a ROE of 21.98%, which is above the benchmark median of 11.78%, a difference of +86.59%. Anthem Biosciences Ltd. (ANTHEM) has a ROCE of 29.62%, which is above the benchmark median of 13.65%, a difference of +117%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,40,277.97 | 36.77 | 5.14 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,965.63 | 83.5 | 13.83 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 84.11 | 20.44 | 26.76 | 19.27 |
| Cipla Ltd. | CIPLA | 1,09,949.53 | 32.59 | 3.12 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,09,625.67 | 24.42 | 4.09 | 19.69 | 21.39 |
Anthem Biosciences Ltd. (ANTHEM) has a P/E ratio of 88.9x compared with the displayed peer median of 36.77x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 21.98% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 29.62% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Anthem Biosciences Ltd. (ANTHEM) has a market capitalisation of Rs 53,106.88 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price rose 2.18% today to Rs 928.40 after trading between Rs 905.00 and Rs 932.05.
- Market capitalisation stands at Rs 53,106.88 crore, which provides the size context for the current Anthem Biosciences Share Price update.
- P/E is 88.9 and P/B is 16.36, both above the same-industry benchmark medians of 31.35 and 2.98.
- ROE of 21.98% and ROCE of 29.62% are both above the benchmark medians of 11.78% and 13.65%.
- EPS of Rs 10.22, book value of Rs 55.53 and dividend yield of 0.22% give additional Anthem Biosciences Fundamental Analysis context.
About Anthem Biosciences
Anthem Biosciences Ltd. operates in Healthcare and is classified in the Pharmaceuticals & Drugs industry.Even so, Anthem Biosciences Share Price remains relevant because the market cap, earnings measures and sector comparison show how the company is being valued relative to the industry. With a P/E of 88.9, P/B of 16.36, ROE of 21.98%, ROCE of 29.62%, EPS of Rs 10.22, book value of Rs 55.53 and dividend yield of 0.22%, the company is clearly priced with a premium earnings and return profile in the current dataset. For readers following Anthem Biosciences Company News, the main point is that the stock’s price movement sits inside a business profile that is still defined more by valuation and returns than by narrative speculation. Univest uses only the verified company facts in this stock update.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences Ltd. (ANTHEM) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Readers can track Anthem Biosciences Share Price on Univest for live share price updates, fundamental ratios, sector context, shareholding pattern, 52-week levels and other market insights. The platform brings together Anthem Biosciences Stock News, Anthem Biosciences Latest News and Anthem Biosciences Stock Analysis in one place so users can review verified data without filtering through scattered sources. Univest also helps users monitor Anthem Biosciences Share Price Today alongside broader market context for better reading of the day’s move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why is Anthem Biosciences Share Price rising today?
Ans. Anthem Biosciences Share Price rose 2.18% today to Rs 928.40. The supplied data confirms the price event, but it does not establish a company-specific catalyst, so the move should be read as a verified market fact.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price Today is Rs 928.40. It moved up from the previous close of Rs 908.60, with the session high at Rs 932.05 and the low at Rs 905.00.
What is Anthem Biosciences market capitalisation?
Ans. Anthem Biosciences Market Cap stands at Rs 53,106.88 crore. That places the company well above the same-industry median market capitalisation of Rs 735.67 crore in the supplied benchmark set. The company operates in the Healthcare sector.
How does Anthem Biosciences compare on valuation?
Ans. Anthem Biosciences Share Price is backed by a P/E of 88.9 and P/B of 16.36. Both are above the same-industry medians of 31.35 and 2.98, which indicates a premium valuation.
What do Anthem Biosciences earnings ratios show?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Both are above the industry benchmark medians, while EPS of Rs 10.22 and book value of Rs 55.53 add more context.
How does Anthem Biosciences look versus peers?
Ans. Anthem Biosciences Share Price compares with peers such as Sun Pharmaceutical, Divi's Laboratories, Torrent Pharmaceuticals, Cipla and Zydus Lifesciences. Its ROCE is above all supplied peers, while its valuation multiples are higher than most.
